Nutritional assessment and medical dietary therapy for management of obesity in patients with non-dialysis chronic kidney disease: a practical guide for endocrinologist, nutritionists and nephrologists. A consensus statement from the Italian society of endocrinology (SIE), working group of the club nutrition-hormones and metabolism; the Italian society of nutraceuticals (SINut), club ketodiets and nutraceuticals "KetoNut-SINut"; and the Italian society of nephrology (SIN).
Bioelectrical impedance analysis
Chronic kidney disease
Diet
Ketogenic diet
Mediterranean diet
Nutrition
Nutritional management
Obesity
Journal
Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594
Informations de publication
Date de publication:
18 Sep 2024
18 Sep 2024
Historique:
received:
08
02
2024
accepted:
19
08
2024
medline:
18
9
2024
pubmed:
18
9
2024
entrez:
18
9
2024
Statut:
aheadofprint
Résumé
Chronic kidney disease (CKD) is a serious health concern with an estimated prevalence of about 13.4% worldwide. It is cause and consequence of various comorbidities, including cardiovascular diseases. In parallel, common pathological conditions closely related to ageing and unhealthy dietary habits increase the risk of CKD development and progression, including type 2 diabetes and obesity. Among these, obesity is either independent risk factor for new onset kidney disease or accelerates the rate of decline of kidney function by multiple mechanisms. Therefore, the role of diets aimed at attaining weight loss in patients with obesity is clearly essential to prevent CKD as to slow disease progression. Various dietary approaches have been licensed for the medical dietary therapy in CKD, including low-protein diet and Mediterranean diet. Interestingly, emerging evidence also support the use of low-carbohydrate/ketogenic diet (LCD/KD) in these patients. More specifically, LCD/KDs may efficiently promote weight loss, improve metabolic parameters, and reduce inflammation and oxidative stress, resulting in a dietary strategy that act globally in managing collateral conditions that are directly and indirectly related to the kidney function. This consensus statement from the Italian Society of Endocrinology (SIE), working group of the Club Nutrition - Hormones and Metabolism; the Italian Society of Nutraceuticals (SINut), Club Ketodiets and Nutraceuticals "KetoNut-SINut"; and the Italian Society of Nephrology (SIN) is intended to be a guide for Endocrinologist, Nutritionists and Nephrologist who deal with the management of patients with obesity with non-dialysis CKD providing a practical guidance on assessing nutritional status and prescribing the optimal diet in order to best manage obesity to prevent CKD and its progression to dialysis.
Identifiants
pubmed: 39292364
doi: 10.1007/s40618-024-02446-8
pii: 10.1007/s40618-024-02446-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).
Références
Hill NR, Fatoba ST, Oke JL et al (2016) Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS One 11:e0158765. https://doi.org/10.1371/journal.pone.0158765
doi: 10.1371/journal.pone.0158765
pubmed: 27383068
pmcid: 4934905
Jage K, Kovesdy C, Langham R et al (2019) A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int 96:1048–1050. https://doi.org/10.1016/j.kint.2019.07.012
doi: 10.1016/j.kint.2019.07.012
Gansevoort RT, Matsushita K, van der Velde M et al (2011) Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney 80:93–104. https://doi.org/10.1038/ki.2010.531
doi: 10.1038/ki.2010.531
Consortium CKDP, Matsushita K, van der Velde M et al (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative metaanalysis. Lancet (London England) 375:2073–2081. https://doi.org/10.1016/S0140-6736(10)60674-5
doi: 10.1016/S0140-6736(10)60674-5
van der Velde M, Matsushita K, Coresh J et al (2011) Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 79:1341–1352. https://doi.org/10.1038/ki.2010.536
doi: 10.1038/ki.2010.536
pubmed: 21307840
Major RW, Cheng MRI, Grant RA et al (2018) Cardiovascular disease risk factors in chronic kidney disease: a systematic review and meta-analysis. PLoS One 13:e0192895. https://doi.org/10.1371/journal.pone.0192895
doi: 10.1371/journal.pone.0192895
pubmed: 29561894
pmcid: 5862400
Rhee CM, Ahmadi SF, Kalantar-Zadeh K (2016) The dual roles of obesity in chronic kidney disease: a review of the current literature. Curr Opin Nephrol Hypertens 25:208–2016. https://doi.org/10.1097/MNH.0000000000000212
doi: 10.1097/MNH.0000000000000212
pubmed: 26999023
pmcid: 5926196
Czaja-Stolc S, Potrykus M, Stankiewicz M et al (2022) Pro-inflammatory profile of adipokines in obesity contributes to pathogenesis, nutritional disorders, and cardiovascular risk in chronic kidney disease. Nutrients 14:1457. https://doi.org/10.3390/nu14071457
doi: 10.3390/nu14071457
pubmed: 35406070
pmcid: 9002635
Stasi A, Cosola C, Caggiano G et al (2022) Obesity-related chronic kidney disease: principal mechanisms and new approaches in nutritional management. Front Nutr 9:925619. https://doi.org/10.3389/fnut.2022.925619
doi: 10.3389/fnut.2022.925619
pubmed: 35811945
pmcid: 9263700
Friedman AN, Kaplan LM, le Roux CW, Schauer PR (2021) Management of obesity in adults with CKD. J Am Soc Nephrol 32:777–790. https://doi.org/10.1681/ASN.2020101472
doi: 10.1681/ASN.2020101472
pubmed: 33602674
pmcid: 8017542
Tsuboi N, Okabayashi Y (2021) The renal pathology of obesity: structure-function correlations. Semin Nephrol 41:296–306. https://doi.org/10.1016/j.semnephrol.2021.06.002
doi: 10.1016/j.semnephrol.2021.06.002
pubmed: 34715960
Garofalo C, Borrell S, Minutolo R et al (2017) A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int 91:1224–1235. https://doi.org/10.1016/j.kint.2016.12.013
doi: 10.1016/j.kint.2016.12.013
pubmed: 28187985
Zeitler EM, Dabb K, Nadeem D et al (2023) Blockbuster medications for obesity: a primer for nephrologists. Am J Kidney Dis 82:762–771. https://doi.org/10.1053/j.ajkd.2023.04.009
doi: 10.1053/j.ajkd.2023.04.009
pubmed: 37500048
De Nicola L, Donfrancesco C, Minutolo R et al (2015) Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008–12 national health examination survey. Nephrol Dial Transplant 30:806–814. https://doi.org/10.1093/ndt/gfu383
doi: 10.1093/ndt/gfu383
pubmed: 25523453
Ikizler TA, Burrowes JD, Byham-Gray LD et al (2020) KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis 76:S1–S107. https://doi.org/10.1053/j.ajkd.2020.05.006
doi: 10.1053/j.ajkd.2020.05.006
pubmed: 32829751
Joshi S, Kalantar-Zadeh K, Chauveau P, Carrero JJ (2023) Risks and benefits of different dietary patterns in CKD. Am J Kidney Dis 81:352–360. https://doi.org/10.1053/j.ajkd.2022.08.013
doi: 10.1053/j.ajkd.2022.08.013
pubmed: 36682903
Chauveau P, Aparicio M, Bellizzi V et al (2018) Mediterranean diet as the diet of choice for patients with chronic kidney disease. Neprhol Dial Transpl 33:725–735. https://doi.org/10.1093/ndt/gfx085
doi: 10.1093/ndt/gfx085
Pérez-Torres A, Caverni-Muñoz A, González García E (2022) Mediterranean diet and chronic kidney disease (CKD): a practical approach. Nutrients 15:97. https://doi.org/10.3390/nu15010097
doi: 10.3390/nu15010097
pubmed: 36615755
pmcid: 9824533
Zainordin NA, Eddy Warman NA, Mohamad AF et al (2021) Safety and efficacy of very low carbohydrate diet in patients with diabetic kidney disease—a randomized controlled trial. PLoS ONE 16:e0258507. https://doi.org/10.1371/journal.pone.0258507
doi: 10.1371/journal.pone.0258507
pubmed: 34644368
pmcid: 8513884
Mitchell NS, Batch BC, Tyson CC (2021) Retrospective cohort study of changes in estimated glomerular filtration rate for patients prescribed a low carb diet. Curr Opin Endocrinol Diabetes Obes 28:480–487. https://doi.org/10.1097/MED.0000000000000673
doi: 10.1097/MED.0000000000000673
pubmed: 34392262
Kundu S, Hossain KS, Moni A et al (2022) Potentials of ketogenic diet against chronic kidney diseases: pharmacological insights and therapeutic prospects. Mol Biol Rep 49:9749–9758. https://doi.org/10.1007/s11033-022-07460-8
doi: 10.1007/s11033-022-07460-8
pubmed: 35441940
Bruci A, Tuccinardi D, Tozzi R et al (2020) Very low-calorie ketogenic diet: a safe and effective tool for weight loss in patients with obesity and mild kidney failure. Nutrients 12:333. https://doi.org/10.3390/nu12020333
doi: 10.3390/nu12020333
pubmed: 32012661
pmcid: 7071259
Goldfarb Cyrino L, Galpern J, Moore L et al (2021) A narrative review of dietary approaches for kidney transplant patients. Kidney Int reports 6:1764–1774. https://doi.org/10.1016/j.ekir.2021.04.009
doi: 10.1016/j.ekir.2021.04.009
Verde L, Lucà S, Cernea S et al (2023) The fat kidney. Curr Obes Rep 12:86–98. https://doi.org/10.1007/s13679-023-00500-9
doi: 10.1007/s13679-023-00500-9
pubmed: 36933154
pmcid: 10250266
Barrea L, Caprio M, Watanabe M et al (2022) Could very low-calorie ketogenic diets turn off low grade inflammation in obesity? emerging evidence. Crit Rev Food Sci Nutr 1:17. https://doi.org/10.1080/10408398.2022.2054935
doi: 10.1080/10408398.2022.2054935
Muscogiuri G, El Ghoch M, Colao A et al (2021) European guidelines for obesity management in adults with a very low-calorie ketogenic diet: a systematic review and meta-analysis. Obes Facts 14:222–245. https://doi.org/10.1159/000515381
doi: 10.1159/000515381
pubmed: 33882506
pmcid: 8138199
Muscogiuri G, Barrea L, Laudisio D et al (2019) The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide. J Transl Med 17:356. https://doi.org/10.1186/s12967-019-2104-z
doi: 10.1186/s12967-019-2104-z
pubmed: 31665015
pmcid: 6820992
Zoccali C, Bellizzi V, Minutolo R et al (2023) The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1–3a CKD patients. Clin Kidney J 16:2309–2313. https://doi.org/10.1093/ckj/sfad176
doi: 10.1093/ckj/sfad176
pubmed: 38045995
pmcid: 10689131
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024) KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105:S117–S314. https://doi.org/10.1016/j.kint.2023.10.018 . (PMID: 38490803)
doi: 10.1016/j.kint.2023.10.018
National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266
National Institute for Health and Care Excellence (NICE) (2021) Chronic kidney disease: assessment and management. London
Fernández P, Nores ML, Douthat W et al (2023) Estimation of glomerular filtration rate in obese patients: utility of a new equation. Nutrients 15:1233. https://doi.org/10.3390/nu15051233
doi: 10.3390/nu15051233
pubmed: 36904233
pmcid: 10004854
Drion I, Joosten H, Santing L et al (2011) The cockcroft-gault: a better predictor of renal function in an overweight and obese diabetic population. Obes Facts 4:393–399. https://doi.org/10.1159/000333399
doi: 10.1159/000333399
pubmed: 22166760
pmcid: 6444492
Lemoine S, Guebre-Egziabher F, Sens F et al (2014) Accuracy of GFR estimation in obese patients. Clin J Am Soc Nephrol 9:720–727. https://doi.org/10.2215/CJN.03610413
doi: 10.2215/CJN.03610413
pubmed: 24482068
pmcid: 3974350
Chang AR, Zafar W, Grams ME (2018) Kidney function in obesity-challenges in indexing and estimation. Adv Chronic Kidney Dis 25:31–40. https://doi.org/10.1053/j.ackd.2017.10.007
doi: 10.1053/j.ackd.2017.10.007
pubmed: 29499884
pmcid: 5836495
Friedman AN, Moe S, Fadel WF et al (2014) Predicting the glomerular filtration rate in bariatric surgery patients. Am J Nephrol 39:8–15. https://doi.org/10.1159/000357231
doi: 10.1159/000357231
pubmed: 24356416
Rothberg AE, McEwen LN, Herman WH (2020) Severe obesity and the impact of medical weight loss on estimated glomerular filtration rate. PLoS ONE 15:e0228984. https://doi.org/10.1371/journal.pone.0228984
doi: 10.1371/journal.pone.0228984
pubmed: 32097414
pmcid: 7041837
Weir VA, Methven S (2020) A practical guide to diagnosis and assessment of chronic kidney disease for the non-nephrologist. J R Coll Physicians Edinb 50:67–74. https://doi.org/10.4997/JRCPE.2020.119
doi: 10.4997/JRCPE.2020.119
pubmed: 32539044
Tsai WC, Wu HY, Peng YS et al (2016) Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta-analysis. Medicine (Baltimore) 95:e3013. https://doi.org/10.1097/MD.0000000000003013
doi: 10.1097/MD.0000000000003013
pubmed: 26986114
Udani S, Lazich I, Bakris GL (2011) Epidemiology of hypertensive kidney disease. Nat Rev Nephrol 7:11–21. https://doi.org/10.1038/nrneph.2010.154
doi: 10.1038/nrneph.2010.154
pubmed: 21079654
Valencia WM, Florez H (2017) How to prevent the microvascular complications of type 2 diabetes beyond glucose control. BMJ 356:i6505. https://doi.org/10.1136/bmj.i6505
doi: 10.1136/bmj.i6505
pubmed: 28096078
Rao IR, Bangera A, Nagaraju SP et al (2023) Chronic kidney disease of unknown aetiology: a comprehensive review of a global public health problem. Trop Med Int Health 28:588–600. https://doi.org/10.1111/tmi.13913
doi: 10.1111/tmi.13913
pubmed: 37403003
Kendrick J, Chonchol M (2008) Renal artery stenosis and chronic ischemic nephropathy: epidemiology and diagnosis. Adv Chronic Kidney Dis 15:355–362. https://doi.org/10.1053/j.ackd.2008.07.004
doi: 10.1053/j.ackd.2008.07.004
pubmed: 18805381
Lombel RM, Brakeman PR, Sack BS, Butani L (2022) Urologic considerations in pediatric chronic kidney disease. Adv Chronic Kidney Dis 29:308–317. https://doi.org/10.1053/j.ackd.2022.02.006
doi: 10.1053/j.ackd.2022.02.006
pubmed: 36084977
Petrucci I, Clementi A, Sessa C et al (2018) Ultrasound and color doppler applications in chronic kidney disease. J Nephrol 31:863–879. https://doi.org/10.1007/s40620-018-0531-1
doi: 10.1007/s40620-018-0531-1
pubmed: 30191413
López-Novoa JM, Rodríguez-Peña AB, Ortiz A et al (2011) Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. J Transl Med 9:13. https://doi.org/10.1186/1479-5876-9-13
doi: 10.1186/1479-5876-9-13
pubmed: 21251296
pmcid: 3034700
Hobby GP, Karaduta O, Dusio GF et al (2019) Chronic kidney disease and the gut microbiome. Am J Physiol Renal Physiol 316:F1211–F1217. https://doi.org/10.1152/ajprenal.00298.2018
doi: 10.1152/ajprenal.00298.2018
pubmed: 30864840
pmcid: 6620595
Amini Khiabani S, Asgharzadeh M, Samadi Kafil H (2023) Chronic kidney disease and gut microbiota. Heliyon 9:e18991. https://doi.org/10.1016/j.heliyon.2023.e18991
doi: 10.1016/j.heliyon.2023.e18991
pubmed: 37609403
pmcid: 10440536
Chen TK, Knicely DH, Grams ME (2019) Chronic kidney disease diagnosis and management: a review. JAMA 322:1294–1304. https://doi.org/10.1001/jama.2019.14745
doi: 10.1001/jama.2019.14745
pubmed: 31573641
pmcid: 7015670
Evans M, Lewis RD, Morgan AR et al (2022) A narrative review of chronic kidney disease in clinical practice: current challenges and future perspectives. Adv Ther 39:33–43. https://doi.org/10.1007/s12325-021-01927-z
doi: 10.1007/s12325-021-01927-z
pubmed: 34739697
Kalantar-Zadeh K, Jafar TH, Nitsch D et al (2021) Chronic kidney disease. Lancet (London, England) 398:786–802. https://doi.org/10.1016/S0140-6736(21)00519-5
doi: 10.1016/S0140-6736(21)00519-5
pubmed: 34175022
Herrington WG, Preiss D, Haynes R et al (2018) The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study. Clin Kidney J 11:749–761. https://doi.org/10.1093/ckj/sfy090
doi: 10.1093/ckj/sfy090
pubmed: 30524708
pmcid: 6275453
Calvert M, Blazeby J, Altman D et al (2013) Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA 309:814–822
doi: 10.1001/jama.2013.879
pubmed: 23443445
Kovesdy CP (2022) Epidemiology of chronic kidney disease: an update. Kidney Int Suppl 12:7–11. https://doi.org/10.1016/j.kisu.2021.11.003
doi: 10.1016/j.kisu.2021.11.003
Qin S, Wang A, Gu S et al (2021) Associa_tion between obesity and urinary albumin-creatinine ratio in the middle-aged and elderly population of Southern and Northern China: a cross-sectional study. BMJ Open 11:e040214. https://doi.org/10.1136/bmjopen-2020-040214
doi: 10.1136/bmjopen-2020-040214
pubmed: 33402405
pmcid: 7786798
Navaneethan SD, Yehnert H, Moustarah F et al (2009) Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 4:1565–1574. https://doi.org/10.2215/CJN.02250409
doi: 10.2215/CJN.02250409
pubmed: 19808241
pmcid: 2758256
Infante M, Armani A, Mammi C et al (2017) Impact of adrenal steroids on regulation of adipose tissue. Compr Physiol 7:1425–1447. https://doi.org/10.1002/cphy.c160037
doi: 10.1002/cphy.c160037
pubmed: 28915330
Mizoguchi A, Banno R, Sun R et al (2021) High-fat feeding causes inflammation and insulin resistance in the ventral tegmental area in mice. Neuroscience 461:72–79. https://doi.org/10.1016/j.neuroscience.2021.02.009
doi: 10.1016/j.neuroscience.2021.02.009
pubmed: 33609637
Rao A, Pandya V, Whaley-Connell A (2015) Obesity and insulin resistance in resistant hypertension: implications for the kidney. Adv Chronic Kidney Dis 22:211–217. https://doi.org/10.1053/j.ackd.2014.12.004
doi: 10.1053/j.ackd.2014.12.004
pubmed: 25908470
de Vries AP, Ruggenenti P, Ruan XZ et al (2014) Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol 2:417–426. https://doi.org/10.1016/S2213-8587(14)70065-8
doi: 10.1016/S2213-8587(14)70065-8
pubmed: 24795255
Seidell JC, Bakx JC, De Boer E et al (1985) Fat distribution of overweight persons in relation to morbidity and subjective health. Int J Obes 9:363–374
pubmed: 4077378
Schetz M, De Jong A, Deane AM et al (2019) Obesity in the critically ill: a narrative review. Intensive Care Med 45:757–769. https://doi.org/10.1007/s00134-019-05594-1
doi: 10.1007/s00134-019-05594-1
pubmed: 30888440
Scaglione R, Ganguzza A, Corrao S et al (1995) Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function. Int J Obes Relat Metab Disord 19:403–409
pubmed: 7550525
Stefansson VTN, Schei J, Solbu MD et al (2018) Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population. Kidney Int 93:1183–1190. https://doi.org/10.1016/j.kint.2017.11.012
doi: 10.1016/j.kint.2017.11.012
pubmed: 29395334
Vega GL, Adams-Huet B, Peshock R et al (2006) Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab 91:4459–4466. https://doi.org/10.1210/jc.2006-0814
doi: 10.1210/jc.2006-0814
pubmed: 16926254
Kawai T, Autieri MA, Scalia R (2021) Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol 320:C375–C391. https://doi.org/10.1152/ajpcell.00379.2020
doi: 10.1152/ajpcell.00379.2020
pubmed: 33356944
Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697–738. https://doi.org/10.1210/edrv.21.6.0415
doi: 10.1210/edrv.21.6.0415
pubmed: 11133069
Wang M, Wang Z, Chen Y, Dong Y (2022) Kidney damage caused by obesity and its feasible treatment drugs. Int J Mol Sci 23:747. https://doi.org/10.3390/ijms23020747
doi: 10.3390/ijms23020747
pubmed: 35054932
pmcid: 8775419
D’Agati VD, Chagnac A, de Vries AP et al (2016) Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol 12:453–471. https://doi.org/10.1038/nrneph.2016.75
doi: 10.1038/nrneph.2016.75
pubmed: 27263398
Briffa JF, McAinch AJ, Poronnik P, Hryciw DH (2013) Adipokines as a link between obesity and chronic kidney disease. Am J Physiol Renal Physiol 305:F1629–F1636. https://doi.org/10.1152/ajprenal.00263.2013
doi: 10.1152/ajprenal.00263.2013
pubmed: 24107418
Chagnac A, Zingerman B, Rozen-Zvi B, Herman-Edelstein M (2019) Consequences of glomerular hyperfiltration: the role of physical forces in the pathogenesis of chronic kidney disease in diabetes and obesity. Nephron 143:38–42. https://doi.org/10.1159/000499486
doi: 10.1159/000499486
pubmed: 30947190
Wei L, Li Y, Yu Y et al (2021) Obesity-related glomerulopathy: from mechanism to therapeutic target. Diabetes Metab Syndr Obes 14:4371–4380. https://doi.org/10.2147/DMSO.S334199
doi: 10.2147/DMSO.S334199
pubmed: 34737593
pmcid: 8560069
Hivert MF, Sullivan LM, Fox CS et al (2008) Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 93:3165–3172. https://doi.org/10.1210/jc.2008-0425
doi: 10.1210/jc.2008-0425
pubmed: 18492747
pmcid: 2515087
Chang A, Van Horn L, Jacobs DR et al (2013) Lifestyle-related factors, obesity, and incident microalbuminuria: the CARDIA (coronary artery risk development in young adults) study. Am J Kidney Dis 62:267–275. https://doi.org/10.1053/j.ajkd.2013.02.363
doi: 10.1053/j.ajkd.2013.02.363
pubmed: 23601954
pmcid: 3720776
Fox CS, Larson MG, Leip EP et al (2004) Predictors of new-onset kidney disease in a community-based population. JAMA 291:844–850. https://doi.org/10.1001/jama.291.7.844
doi: 10.1001/jama.291.7.844
pubmed: 14970063
Gelber RP, Kurth T, Kausz AT et al (2005) Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 46:871–880. https://doi.org/10.1053/j.ajkd.2005.08.015
doi: 10.1053/j.ajkd.2005.08.015
pubmed: 16253727
Foster MC, Hwang SJ, Larson MG et al (2008) Overweight, obesity, and the development of stage 3 CKD: the framingham heart study. Foster M C, Hwang, S J, Larson, M G, Lichtman, J H, Parikh, N I, Vasan, R S, Levy, D, Fox, C S 52:39–48. https://doi.org/10.1053/j.ajkd.2008.03.003
doi: 10.1053/j.ajkd.2008.03.003
Hsu CY, McCulloch CE, Iribarren C et al (2006) Body mass index and risk for end-stage renal disease. Ann Intern Med 144:21–28. https://doi.org/10.7326/0003-4819-144-1-200601030-00006
doi: 10.7326/0003-4819-144-1-200601030-00006
pubmed: 16389251
Lan J, Xu G, Zhu Y et al (2023) Association of body mass index and acute kidney injury incidence and outcome: a systematic review and meta-analysis. J Ren Nutr 33:397–404. https://doi.org/10.1053/j.jrn.2023.01.005
doi: 10.1053/j.jrn.2023.01.005
pubmed: 36731684
Piccoli GB, Cederholm T, Avesani CM et al (2023) Nutritional status and the risk of malnutrition in older adults with chronic kidney disease—implications for low protein intake and nutritional care: a critical review endorsed by ERN-ERA and ESPEN. Clin Nutr 42:443–457. https://doi.org/10.1016/j.clnu.2023.01.018
doi: 10.1016/j.clnu.2023.01.018
pubmed: 36857954
Fouque D, Kalantar-Zadeh K, Kopple J et al (2008) A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73:391–398. https://doi.org/10.1038/sj.ki.5002585
doi: 10.1038/sj.ki.5002585
pubmed: 18094682
Bellizzi V, Di Iorio BR, Brunori G et al (2010) Assessment of nutritional practice in Italian chronic kidney disease clinics: a questionnaire-based survey. J Ren Nutr 20:82–90. https://doi.org/10.1053/j.jrn.2009.05.001
doi: 10.1053/j.jrn.2009.05.001
pubmed: 19616451
Bharadwaj S, Ginoya S, Tandon P et al (2016) Malnutrition: laboratory markers vs nutritional assessment. Gastroenterol Rep 4:272–280. https://doi.org/10.1093/gastro/gow013
doi: 10.1093/gastro/gow013
World Health Organization W BMI Categories. https://www.who.int . Accessed 3 Sep 2023
Marra M, Sammarco R, De Lorenzo A et al (2019) Assessment of body composition in health and disease using bioelectrical impedance analysis (BIA) and dual energy X-ray absorptiometry (DXA): a critical overview. Contrast Media Mol Imaging eCollectio. https://doi.org/10.1155/2019/3548284
doi: 10.1155/2019/3548284
Messina C, Albano D, Gitto S et al (2020) Body composition with dual energy X-ray absorptiometry from basics to new tools. Quant Imaging Med Surg. https://doi.org/10.21037/qims.2020.03.02
doi: 10.21037/qims.2020.03.02
pubmed: 32742961
pmcid: 7378094
Bellizzi V, Scalfi L, Terracciano V et al (2006) Early changes in bioelectrical estimates of body composition in chronic kidney disease. J Am Soc Nephrol 17:1481–1487. https://doi.org/10.1681/ASN.2005070756
doi: 10.1681/ASN.2005070756
pubmed: 16611719
Miranda Alatriste PV, Ramírez EC, Carsi XA et al (2022) Hydration status according to impedance vectors and its association with clinical and biochemical outcomes and mortality in patients with chronic kidney disease. Nutr Hosp 39:1037–1046. https://doi.org/10.20960/nh.03970
doi: 10.20960/nh.03970
pubmed: 36134595
Reljic D, Zarafat D, Jensen B et al (2020) Phase angle and vector analysis from multifrequency segmental bioelectrical impedance analysis: new reference data for older adults. J Phys Pharmacol Off J Polish Physiol Soc. https://doi.org/10.26402/jpp.2020.4.04
doi: 10.26402/jpp.2020.4.04
Norman K, Stobäus N, Pirlich M, Bosy-Westphal A (2012) Bioelectrical phase angle and impedance vector analysis–clinical relevance and applicability of impedance parameters. Clin Nutr 31:854–861. https://doi.org/10.1016/j.clnu.2012.05.008
doi: 10.1016/j.clnu.2012.05.008
pubmed: 22698802
Barrea L, Muscogiuri G, Pugliese G et al (2021) Phase angle as an easy diagnostic tool of meta-inflammation for the nutritionist. Nutrients 13:1446. https://doi.org/10.3390/nu13051446
doi: 10.3390/nu13051446
pubmed: 33923291
pmcid: 8145306
Barrea L, Pugliese G, de Alteriis G et al (2020) Phase angle: could be an easy tool to detect low-grade systemic inflammation in adults affected by prader-willi syndrome? Nutrients 12:2065. https://doi.org/10.3390/nu12072065
doi: 10.3390/nu12072065
pubmed: 32664600
pmcid: 7400955
Barrea L, Muscogiuri G, Aprano S et al (2022) Phase angle as an easy diagnostic tool for the nutritionist in the evaluation of inflammatory changes during the active stage of a very low-calorie ketogenic diet. Int J Obes (Lond) 46:1591–1597. https://doi.org/10.1038/s41366-022-01152-w
doi: 10.1038/s41366-022-01152-w
pubmed: 35614205
Chawla A, Nguyen KD, Goh YP (2011) Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol 11:738–749. https://doi.org/10.1038/nri3071
doi: 10.1038/nri3071
pubmed: 21984069
pmcid: 3383854
Zatterale F, Longo M, Naderi J et al (2020) Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol 10:1607. https://doi.org/10.3389/fphys.2019.01607
doi: 10.3389/fphys.2019.01607
pubmed: 32063863
pmcid: 7000657
Crinò A, Fintini D, Bocchini S, Grugni G (2018) Obesity management in prader-willi syndrome: current perspectives. Diabetes Metab Syndr Obes 11:579–593. https://doi.org/10.2147/DMSO.S141352
doi: 10.2147/DMSO.S141352
pubmed: 30323638
pmcid: 6175547
Bansal N, Zelnick LR, Himmelfarb J, Chertow GM (2018) Bioelectrical impedance analysis measures and clinical outcomes in CKD. Am J Kidney Dis 72:662–672. https://doi.org/10.1053/j.ajkd.2018.03.030
doi: 10.1053/j.ajkd.2018.03.030
pubmed: 29885923
Zhou H, Yao W, Pan D, Sun G (2021) Predicational ability of phase angle on protein energy wasting in kidney disease patients with renal replacement therapy: a cross-sectional study. Food Sci Nutr 9:3573–3579. https://doi.org/10.1002/fsn3.2310
doi: 10.1002/fsn3.2310
pubmed: 34262718
pmcid: 8269568
Piccoli A, Piazza P, Noventa D et al (1996) A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Med sci Sport Exerc 28:1517–1522. https://doi.org/10.1097/00005768-199612000-00012
doi: 10.1097/00005768-199612000-00012
Piccoli A, Pillon L, Dumler F (2002) Impedance vector distribution by sex, race, body mass index, and age in the United States: standard reference intervals as bivariate Z scores. Nutrition 18:153–167. https://doi.org/10.1016/s0899-9007(01)00665-7
doi: 10.1016/s0899-9007(01)00665-7
pubmed: 11844647
James PA, Oparil S, Carter BL et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA 311:507–520. https://doi.org/10.1001/jama.2013.284427
doi: 10.1001/jama.2013.284427
pubmed: 24352797
Lee YL, Jin H, Lim J-Y, Lee SY (2021) Relationship between low handgrip strength and chronic kidney disease: KNHANES 2014–2017. J Ren Nutr 31:57–63
doi: 10.1053/j.jrn.2020.03.002
pubmed: 32381354
He P, Ye Z, Liu M et al (2023) Association of handgrip strength and/or walking pace with incident chronic kidney disease: a UK biobank observational study. J Cachexia Sarcopenia Muscle 14:805–814. https://doi.org/10.1002/jcsm.13180
doi: 10.1002/jcsm.13180
pubmed: 36708151
pmcid: 10067488
Kim JK, Choi SR, Choi MJ et al (2014) Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr 33:64–68. https://doi.org/10.1016/j.clnu.2013.04.002
doi: 10.1016/j.clnu.2013.04.002
pubmed: 23631844
Souza VA, Oliveira D, Barbosa SR et al (2017) Sarcopenia in patients with chronic kidney disease not yet on dialysis: analysis of the prevalence and associated factors. PLoS One 12:e0176230. https://doi.org/10.1371/journal.pone.0176230
doi: 10.1371/journal.pone.0176230
pubmed: 28448584
pmcid: 5407780
Hanatani S, Izumiya Y, Onoue Y et al (2018) Non-invasive testing for sarcopenia predicts future cardiovascular events in patients with chronic kidney disease. Int J Cardiol 268:216–221. https://doi.org/10.1016/j.ijcard.2018.03.064
doi: 10.1016/j.ijcard.2018.03.064
pubmed: 29650344
Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:601. https://doi.org/10.1093/ageing/afz046
doi: 10.1093/ageing/afz046
pubmed: 31081853
pmcid: 6593317
Dodds RM, Granic A, Robinson SM, Sayes AA (2020) Sarcopenia, long-term conditions, and multimorbidity: findings from UK biobank participants. J Cachexia Sarcopenia Muscle 11:62–68. https://doi.org/10.1002/jcsm.12503
doi: 10.1002/jcsm.12503
pubmed: 31886632
Pereira RA, Cordeiro AC, Avesani CM et al (2015) Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Ren Assoc 30:1718–1725. https://doi.org/10.1093/ndt/gfv133
doi: 10.1093/ndt/gfv133
Hwang S-H, Lee DH, Min J, Jeon JY (2019) Handgrip strength as a predictor of all-cause mortality in patients with chronic kidney disease undergoing dialysis: a meta-analysis of prospective cohort studies. J Ren Nutr 29:471–479. https://doi.org/10.1053/j.jrn.2019.01.002
doi: 10.1053/j.jrn.2019.01.002
pubmed: 30827839
Vogt BP, Borges MCC, Goés CR, Caramori JCT (2016) Handgrip strength is an independent predictor of all-cause mortality in maintenance dialysis patients. Clin Nutr 35:1429–1433. https://doi.org/10.1016/j.clnu.2016.03.020
doi: 10.1016/j.clnu.2016.03.020
pubmed: 27083497
DeFronzo RA, Tripathy D (2009) Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 32(Suppl 2):S157–S163. https://doi.org/10.2337/dc09-S302
doi: 10.2337/dc09-S302
pubmed: 19875544
pmcid: 2811436
De Cosmo S, Menzaghi C, Prudente S, Trischitta V (2013) Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence. Nephrol Dial Transpl 28:29–36. https://doi.org/10.1093/ndt/gfs290
doi: 10.1093/ndt/gfs290
Ji LL (2007) Antioxidant signaling in skeletal muscle: a brief review. Exp Gerontol 42:582–593. https://doi.org/10.1016/j.exger.2007.03.002
doi: 10.1016/j.exger.2007.03.002
pubmed: 17467943
Nielsen S, Pedersen BK (2008) Skeletal muscle as an immunogenic organ. Curr Opin Pharmacol 8:346–351. https://doi.org/10.1016/j.coph.2008.02.005
doi: 10.1016/j.coph.2008.02.005
pubmed: 18417420
Bellizzi V, Calella P, Hernández JN et al (2018) Safety and effectiveness of low-protein diet supplemented with ketoacids in diabetic patients with chronic kidney disease. BMC Nephrol 19:110. https://doi.org/10.1186/s12882-018-0914-5
doi: 10.1186/s12882-018-0914-5
pubmed: 29743031
pmcid: 5944089
Kalantar-Zadeh K, Bellizzi V, Piccoli G et al (2023) Caring for patients with advanced chronic kidney disease: dietary options and conservative care instead of maintenance dialysis. J Ren Nutr 33:508–519. https://doi.org/10.1053/j.jrn.2023.02.002
doi: 10.1053/j.jrn.2023.02.002
pubmed: 36796502
Palmer SC, Maggo JK, Campbell KL et al (2017) Dietary interventions for adults with chronic kidney disease. Cochrane database Syst Rev. https://doi.org/10.1002/14651858.CD011998.pub2
doi: 10.1002/14651858.CD011998.pub2
pubmed: 28782299
pmcid: 6483666
Casas-Agustench P, Salas-Huetos A, Salas-Salvadó J (2011) Mediterranean nuts: origins, ancient medicinal benefits and symbolism. Public Heal Nutr 14:2296–2310. https://doi.org/10.1017/s1368980011002540
doi: 10.1017/s1368980011002540
Davis C, Bryan J, Hodgson J, Murphy K (2015) Definition of the Mediterranean diet; a literature review. Nutrients 7:9139–9153. https://doi.org/10.3390/nu7115459
doi: 10.3390/nu7115459
pubmed: 26556369
pmcid: 4663587
de Lorgeril M, Salen P, Rabaeus M (2019) New and traditional foods in a modernized Mediterranean diet model. Eur J Clin Nutr 72:47–54. https://doi.org/10.1038/s41430-018-0308-6
doi: 10.1038/s41430-018-0308-6
pubmed: 30487564
Estruch R, Ros E (2020) The role of the Mediterranean diet on weight loss and obesity-related diseases. Rev Endocr Metab Disord 21:315–327. https://doi.org/10.1007/s11154-020-09579-0
doi: 10.1007/s11154-020-09579-0
pubmed: 32829455
Muscogiuri G, Verde L, Sulu C et al (2022) Mediterranean diet and obesity-related disorders: what is the evidence? Curr Obes Rep 11:257–304. https://doi.org/10.1007/s13679-022-00481-1
doi: 10.1007/s13679-022-00481-1
Barrea L, Verde L, Annunziata G et al (2024) Role of Mediterranean diet in endocrine diseases: a joint overview by the endocrinologist and the nutritionist. J Endocrinol Invest 47:17–33. https://doi.org/10.1007/s40618-023-02169-2
doi: 10.1007/s40618-023-02169-2
pubmed: 37697017
Sánchez-Villegas A, Bes-Rastrollo M, Martínez-González MA, Serra-Majem L (2006) Adherence to a Mediterranean dietary pattern and weight gain in a follow-up study: the sun cohort. Int J Obes (Lond) 30:350–358. https://doi.org/10.1038/sj.ijo.0803118
doi: 10.1038/sj.ijo.0803118
pubmed: 16231028
Schröder H, Marrugat J, Vila J et al (2004) Adherence to the traditional Mediterranean diet is inversely associated with body mass index and obesity in a spanish population. J Nutr 134:3355–3361. https://doi.org/10.1093/jn/134.12.3355
doi: 10.1093/jn/134.12.3355
pubmed: 15570037
Poulimeneas D, Anastasiou CA, Santos I et al (2020) Exploring the relationship between the Mediterranean diet and weight loss maintenance: the MedWeight study. Br J Nutr 124:874–880. https://doi.org/10.1017/S0007114520001798
doi: 10.1017/S0007114520001798
pubmed: 32436489
pmcid: 9105806
Esposito K, Kastorini CM, Panagiotakos DB, Giugliano D (2011) Mediterranean diet and weight loss: meta-analysis of randomized controlled trials. Metab Syndr Relat Disord 9:1–12. https://doi.org/10.1089/met.2010.0031
doi: 10.1089/met.2010.0031
pubmed: 20973675
Mancini JG, Filion KB, Atallah R, Eisenberg MJ (2016) Systematic review of the Mediterranean diet for long-term weight loss. Am J Med 129:407-415.e4. https://doi.org/10.1016/j.amjmed.2015.11.028
doi: 10.1016/j.amjmed.2015.11.028
pubmed: 26721635
Caldiroli L, Molinari P, Abinti M et al (2022) Can Mediterranean diet have a positive impact on kidney health? a pending answer to a long-time question. Nutrients 14:4366. https://doi.org/10.3390/nu14204366
doi: 10.3390/nu14204366
pubmed: 36297050
pmcid: 9608621
Hansrivijit P, Oli S, Khanal R et al (2020) Mediterranean diet and the risk of chronic kidney disease: a systematic review and meta-analysis. Nephrology (Carlton) 25:913–918. https://doi.org/10.1111/nep.13778
doi: 10.1111/nep.13778
pubmed: 32852121
Buades Fuster JM, Sanchís Cortés P, Perelló Bestard J, Grases Freixedas F (2017) Plant phosphates, phytate and pathological calcifications in chronic kidney disease. Nefrologia 37:20–28. https://doi.org/10.1016/j.nefro.2016.07.001
doi: 10.1016/j.nefro.2016.07.001
pubmed: 27697413
Kalantar-Zadeh K, Gutekunst L, Mehrotra R et al (2010) Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 5:519–530. https://doi.org/10.2215/CJN.06080809
doi: 10.2215/CJN.06080809
pubmed: 20093346
Natale P, Palmer SC, Ruospo M et al (2020) Potassium binders for chronic hyperkalaemia in people with chronic kidney disease. Cochrane database Syst Rev. https://doi.org/10.1002/14651858.CD013165.pub2
doi: 10.1002/14651858.CD013165.pub2
pubmed: 33107592
pmcid: 8094274
De Nicola L, Garofalo C, Borrelli S, Minutolo R (2022) Recommendations on nutritional intake of potassium in CKD: it’s now time to be more flexible! Kidney Int 102:700–703. https://doi.org/10.1016/j.kint.2022.04.046
doi: 10.1016/j.kint.2022.04.046
pubmed: 36150763
Carrero JJ, González-Ortiz A, Avesani CM et al (2020) Plant-based diets to manage the risks and complications of chronic kidney disease. Nat Rev Nephrol 16:525–542. https://doi.org/10.1038/s41581-020-0297-2
doi: 10.1038/s41581-020-0297-2
pubmed: 32528189
Kim H, Caulfield L, Garcia-Larsen V et al (2019) Plant-based diets and incident CKD and kidney function. Clin J Am Soc Nephrol 14:682–691. https://doi.org/10.2215/CJN.12391018
doi: 10.2215/CJN.12391018
pubmed: 31023928
pmcid: 6500948
Heo G, Koh H, Kim H et al (2023) Association of plant protein intake with risk of incident CKD: a UK biobank study. Am J Kidney Dis 82:687–697. https://doi.org/10.1053/j.ajkd.2023.05.007
doi: 10.1053/j.ajkd.2023.05.007
pubmed: 37517545
Kramer H, Shoham D (2019) The millennial physician and the obesity epidemic: a tale of sugar-sweetened beverages. Clin J Am Soc Nephrol 14:4–6. https://doi.org/10.2215/CJN.13851118
doi: 10.2215/CJN.13851118
pubmed: 30591518
Martini D (2019) Health benefits of Mediterranean diet. Nutrients 11:1802. https://doi.org/10.3390/nu11081802
doi: 10.3390/nu11081802
pubmed: 31387226
pmcid: 6723598
Picard K, Senior PA, Adame Perez S et al (2021) Low Mediterranean diet scores are associated with reduced kidney function and health related quality of life but not other markers of cardiovascular risk in adults with diabetes and chronic kidney disease. Nutr Metab Cardiovasc Dis 31:1445–1453. https://doi.org/10.1016/j.numecd.2021.02.002
doi: 10.1016/j.numecd.2021.02.002
pubmed: 33812736
Bayán-Bravo A, Banegas JR, Donat-Vargas C et al (2022) The Mediterranean diet protects renal function in older adults: a prospective cohort study. Nutrients 14:432. https://doi.org/10.3390/nu14030432
doi: 10.3390/nu14030432
pubmed: 35276791
pmcid: 8839505
Jankowski J, Floege J, Fliser D et al (2021) Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143:1157–1172. https://doi.org/10.1161/circulationaha.120.050686
doi: 10.1161/circulationaha.120.050686
pubmed: 33720773
pmcid: 7969169
Martínez-González MA, Gea A, Ruiz-Canela M (2019) The Mediterranean diet and cardiovascular health: a critical review. Circ Res 124:779–798. https://doi.org/10.1161/CIRCRESAHA.118.313348
doi: 10.1161/CIRCRESAHA.118.313348
pubmed: 30817261
Goraya N, Munoz-Maldonado Y, Simoni J, Wesson DE (2019) Fruit and vegetable treatment of chronic kidney disease-related metabolic acidosis reduces cardiovascular risk better than sodium bicarbonate. Am J Nephrol 49:438–448. https://doi.org/10.1159/000500042
doi: 10.1159/000500042
pubmed: 30995657
Podadera-Herreros A, Alcala-Diaz JF, Gutierrez-Mariscal FM et al (2022) Long-term consumption of a Mediterranean diet or a low-fat diet on kidney function in coronary heart disease patients: the CORDIOPREV randomized controlled trial. Clin Nutr 41:552–559. https://doi.org/10.1016/j.clnu.2021.12.041
doi: 10.1016/j.clnu.2021.12.041
pubmed: 35030530
Barrea L, Caprio M, Camajani E et al (2024) Ketogenic nutritional therapy (KeNuT)-a multi-step dietary model with meal replacements for the management of obesity and its related metabolic disorders: a consensus statement from the working group of the club of the Italian society of endocrinology SI. J Endocrinol Invest Adv. https://doi.org/10.1007/s40618-023-02258-2
doi: 10.1007/s40618-023-02258-2
Paoli A, Bianco A, Moro T et al (2023) The effects of ketogenic diet on insulin sensitivity and weight loss, which came first: the chicken or the egg? Nutrients 15:3120. https://doi.org/10.3390/nu15143120
doi: 10.3390/nu15143120
pubmed: 37513538
pmcid: 10385501
Barrea L, Caprio M, Grassi D et al (2024) A new nomenclature for the very low-calorie ketogenic diet (VLCKD): very low-energy ketogenic therapy (VLEKT). Ketodiets and nutraceuticals expert panels: “KetoNut”, Italian Society of Nutraceuticals (SINut) and the Italian Association of Dietetics and Clinical Nutrition (ADI). Curr Nutr Rep 13:552–556 (2024). https://doi.org/10.1007/s13668-024-00560-w
doi: 10.1007/s13668-024-00560-w
pubmed: 39039372
pmcid: 11327192
Zhou MS, Wang A, Yu H (2014) Link between insulin resistance and hypertension: what is the evidence from evolutionary biology? Diabetol Metab Syndr 6:12. https://doi.org/10.1186/1758-5996-6-12
doi: 10.1186/1758-5996-6-12
pubmed: 24485020
pmcid: 3996172
DeFronzo RA (1981) The effect of insulin on renal sodium metabolism. Rev Clin Implic Diabetol 21:165–171. https://doi.org/10.1007/BF00252649
doi: 10.1007/BF00252649
Suyoto PST (2018) Effect of low-carbohydrate diet on markers of renal function in patients with type 2 diabetes: a meta-analysis. Diabetes Metab Res Rev 34:e3032. https://doi.org/10.1002/dmrr.3032
doi: 10.1002/dmrr.3032
pubmed: 29904998
Oyabu C, Hashimoto Y, Fukuda T et al (2016) Impact of low-carbohydrate diet on renal function: a meta-analysis of over 1000 individuals from nine randomised controlled trials. Br J Nutr 116:632–638. https://doi.org/10.1017/S0007114516002178
doi: 10.1017/S0007114516002178
pubmed: 27346534
Juraschek SP, Chang AR, Appel LJ et al (2016) Effect of glycemic index and carbohydrate intake on kidney function in healthy adults. BMC Nephrol 17:70. https://doi.org/10.1186/s12882-016-0288-5
doi: 10.1186/s12882-016-0288-5
pubmed: 27391484
pmcid: 4938908
Caprio M, Infante M, Moriconi E et al (2019) Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the italian society of endocrinology (SIE). J Endocrinol Invest 42:1365–1368. https://doi.org/10.1007/s40618-019-01061-2
doi: 10.1007/s40618-019-01061-2
pubmed: 31111407
Tomita I, Kume S, Sugahara S et al (2020) SGLT2 inhibition mediates protection from diabetic kidney disease by promoting ketone body-induced mTORC1 inhibition. Cell Metab 32:404–419. https://doi.org/10.1016/j.cmet.2020.06.020
doi: 10.1016/j.cmet.2020.06.020
pubmed: 32726607
Puchalska P, Crawford PA (2017) Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab 25:262–284. https://doi.org/10.1016/j.cmet.2016.12.022
doi: 10.1016/j.cmet.2016.12.022
pubmed: 28178565
pmcid: 5313038
Greco T, Glenn TC, Hovda DA, Prins ML (2016) Ketogenic diet decreases oxidative stress and improves mitochondrial respiratory complex activity. J Cereb Blood Flow Metab 36:1603–1613. https://doi.org/10.1177/0271678X15610584
doi: 10.1177/0271678X15610584
pubmed: 26661201
Paoli A, Cancellara P, Pompei P, Moro T (2019) Ketogenic diet and skeletal muscle hypertrophy: a frenemy relationship? J Hum Kinet 68:233–247. https://doi.org/10.2478/hukin-2019-0071
doi: 10.2478/hukin-2019-0071
pubmed: 31531148
pmcid: 6724590
Brinkworth GD, Buckley JD, Noakes M, Clifton PM (2010) Renal function following long-term weight loss in individuals with abdominal obesity on a very-low-carbohydrate diet vs high-carbohydrate diet. J Am Diet Assoc 110:633–638. https://doi.org/10.1016/j.jada.2009.12.016
doi: 10.1016/j.jada.2009.12.016
pubmed: 20338292
Tirosh A, Golan R, Harman-Boehm I et al (2013) Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care 36:2225–2232. https://doi.org/10.2337/dc12-1846
doi: 10.2337/dc12-1846
pubmed: 23690533
pmcid: 3714527
Lambert K, Beer J, Dumont R et al (2018) Weight management strategies for those with chronic kidney disease: a consensus report from the asia pacific society of nephrology and Australia and New Zealand society of nephrology 2016 renal dietitians meeting. Nephrology (Carlton) 23:912–920. https://doi.org/10.1111/nep.13118
doi: 10.1111/nep.13118
pubmed: 28742255
Barrea L, Verde L, Vetrani C et al (2022) VLCKD: a real time safety study in obesity. J Transl Med 20:23. https://doi.org/10.1186/s12967-021-03221-6
doi: 10.1186/s12967-021-03221-6
pubmed: 34998415
pmcid: 8742928
Goday A, Bellido D, Sajoux I et al (2016) Short-term safety, tolerability and efficacy of a very low_calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus. Nutr Diabetes 6:e230. https://doi.org/10.1038/nutd.2016.36
doi: 10.1038/nutd.2016.36
pubmed: 27643725
pmcid: 5048014
Lew QJ, Jafar TH, Koh HW et al (2017) Red meat intake and risk of ESRD. J Am Soc Nephrol 28:304–312. https://doi.org/10.1681/ASN.2016030248
doi: 10.1681/ASN.2016030248
pubmed: 27416946
Azadbakht L, Shakerhosseini R, Atabak S et al (2003) Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr 57:1292–1294. https://doi.org/10.1038/sj.ejcn.1601688
doi: 10.1038/sj.ejcn.1601688
pubmed: 14506491
Jibani MM, Bloodworth LL, Foden E et al (1991) Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: effects on albumin excretion rate and nutritional status. Diabet Med 8:949–953. https://doi.org/10.1111/j.1464-5491.1991.tb01535.x
doi: 10.1111/j.1464-5491.1991.tb01535.x
pubmed: 1838047
Kontessis P, Jones S, Dodds R et al (1990) Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int 38:136–144. https://doi.org/10.1038/ki.1990.178
doi: 10.1038/ki.1990.178
pubmed: 2166857
Tougaard N, Faber J, Eldrup E (2019) Very low carbohydrate diet and SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis. BMJ Case Rep 12:e227516. https://doi.org/10.1136/bcr-2018-227516
doi: 10.1136/bcr-2018-227516
pubmed: 30954957
pmcid: 6453281